Literature DB >> 15221292

Challenging the neuronal MIBG uptake by pharmacological intervention: effect of a single dose of oral amitriptyline on regional cardiac MIBG uptake.

Montserrat Estorch1, Ignasi Carrió, Esther Mena, Albert Flotats, Valle Camacho, Jordi Fuertes, Jaume Kulisewsky, Jagat Narula.   

Abstract

PURPOSE: Imaging with metaiodobenzylguanidine (MIBG) is used for the assessment of neuronal dysfunction in various cardiovascular disorders. Although valuable information is obtained by resting MIBG imaging, it is conceivable that competitive interference with the re-uptake mechanism would exaggerate MIBG defects and might unmask subclinical neuronal dysfunction. Tricyclic antidepressants, such as amitriptyline, have been reported to significantly increase cardiac MIBG washout and inhibit uptake into presynaptic neurons. This study was undertaken to assess whether a single oral dose of amitriptyline could influence cardiac MIBG distribution.
METHODS: Six patients (aged 62-81 years; four males, two females) who had demonstrated a normal cardiac MIBG scan during work-up for movement disorders were studied. The patients underwent a second 123I-MIBG study after oral administration of 25 mg amitriptyline within 1 week. Single-photon emission computed tomography images were acquired at 4 h to assess the regional distribution of MIBG, after generation of polar maps and employing a 20-segment model. Mean percentage of peak activity was calculated for each segment at rest and after amitriptyline administration.
RESULTS: After amitriptyline administration, there was a decrease in regional MIBG uptake in 10+/-4 segments per patient [62/120 segments (52%): 37 segments with a 5-10% decrease, 25 segments with a >10% decrease]. This change was statistically significant in lateral (P=0.003), apical (P<0.0001) and inferior (P=0.03) regions.
CONCLUSION: A single oral dose of amitriptyline can induce changes in the uptake and retention of cardiac MIBG, indicating the feasibility of use of pharmacological intervention in cardiac neurotransmission imaging.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221292     DOI: 10.1007/s00259-004-1520-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  26 in total

1.  Imaging guidelines for nuclear cardiology procedures, part 2. American Society of Nuclear Cardiology.

Authors: 
Journal:  J Nucl Cardiol       Date:  1999 Mar-Apr       Impact factor: 5.952

2.  Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography.

Authors:  J Yamazaki; H Muto; T Kabano; S Yamashina; S Nanjo; A Inoue
Journal:  Am Heart J       Date:  2001-04       Impact factor: 4.749

3.  Carvedilol improves left ventricular function in heart failure patients with idiopathic dilated cardiomyopathy and a wide range of sympathetic nervous system function as measured by iodine 123 metaiodobenzylguanidine.

Authors:  Myron C Gerson; Laura L Craft; Nancy McGuire; Damodhar P Suresh; William T Abraham; Lynne E Wagoner
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

4.  Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy.

Authors:  P Merlet; C Benvenuti; D Moyse; F Pouillart; J L Dubois-Randé; A M Duval; D Loisance; A Castaigne; A Syrota
Journal:  J Nucl Med       Date:  1999-06       Impact factor: 10.057

5.  Scintigraphic assessment of regional cardiac adrenergic innervation.

Authors:  M W Dae; J W O'Connell; E H Botvinick; T Ahearn; E Yee; J P Huberty; H Mori; M C Chin; R S Hattner; J M Herre
Journal:  Circulation       Date:  1989-03       Impact factor: 29.690

Review 6.  Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response.

Authors:  P J Perry; C Zeilmann; S Arndt
Journal:  J Clin Psychopharmacol       Date:  1994-08       Impact factor: 3.153

7.  Measuring acute changes in adrenergic nerve activity of the heart in the living animal.

Authors:  J C Sisson; G Bolgos; J Johnson
Journal:  Am Heart J       Date:  1991-04       Impact factor: 4.749

8.  Myocardial iodine-labeled metaiodobenzylguanidine 123 uptake relates to age.

Authors:  M Estorch; I Carrió; L Berná; J López-Pousa; G Torres
Journal:  J Nucl Cardiol       Date:  1995 Mar-Apr       Impact factor: 5.952

9.  Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy.

Authors:  J S Gill; G J Hunter; G Gane; A J Camm
Journal:  Am Heart J       Date:  1993-08       Impact factor: 4.749

10.  Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol therapy.

Authors:  Takuji Toyama; Hiroshi Hoshizaki; Ryotaro Seki; Naoki Isobe; Hitoshi Adachi; Shigeto Naito; Shigeru Oshima; Koichi Taniguchi
Journal:  J Nucl Med       Date:  2003-10       Impact factor: 10.057

View more
  6 in total

Review 1.  Cardiac neurotransmission SPECT imaging.

Authors:  Albert Flotats; Ignasi Carrió
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

2.  Highlights of the Annual Congress of the European Association of Nuclear Medicine, Helsinki 2004, and a dash of horizon scanning.

Authors:  Peter J Ell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-01       Impact factor: 9.236

Review 3.  Impact of medications on mIBG uptake, with specific attention to the heart: Comprehensive review of the literature.

Authors:  Arnold F Jacobson; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2015-05-15       Impact factor: 5.952

Review 4.  Radionuclide imaging of cardiac sympathetic innervation in heart failure: unlocking untapped potential.

Authors:  Shuchita Gupta; Aman Amanullah
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

5.  European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma.

Authors:  David Taïeb; Rodney J Hicks; Elif Hindié; Benjamin A Guillet; Anca Avram; Pietro Ghedini; Henri J Timmers; Aaron T Scott; Saeed Elojeimy; Domenico Rubello; Irène J Virgolini; Stefano Fanti; Sona Balogova; Neeta Pandit-Taskar; Karel Pacak
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-29       Impact factor: 9.236

6.  EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma.

Authors:  David Taïeb; Henri J Timmers; Elif Hindié; Benjamin A Guillet; Hartmut P Neumann; Martin K Walz; Giuseppe Opocher; Wouter W de Herder; Carsten C Boedeker; Ronald R de Krijger; Arturo Chiti; Adil Al-Nahhas; Karel Pacak; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-08-28       Impact factor: 9.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.